SCHEMBL10302273

SCHEMBL10302273

C/C=C/c1ccc(OCc2ccc(-c3ccc(OCC)c(F)c3F)cc2)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB1 Q9H4B7 2/20 0.44
▸ KDM4E B2RXH2 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TACR2 P21452 1/20 0.40
▸ FFAR1 O14842 2/20 0.39
▸ PPARD Q03181 2/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ GAA P10253 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ TNFRSF1A P19438 1/20 0.39
▸ PKM P14618 2/20 0.37
▸ NTSR1 P30989 1/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.36
▸ KCNA3 P22001 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ MITF O75030 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12717072 0.93 FFAR1 (0.40) TUBB1KDM4ELMNATACR2FFAR1
SCHEMBL12736498 0.92 TACR2 (0.41) TUBB1KDM4ELMNATACR2FFAR1
SCHEMBL12740943 0.92 TACR2 (0.41) TUBB1KDM4ELMNATACR2FFAR1
SCHEMBL12739568 0.89 TUBB1 (0.51) TUBB1KDM4EFFAR1PPARDPPARG
SCHEMBL12740978 0.89 FFAR1 (0.47) TUBB1TACR2FFAR1PPARDPPARG
SCHEMBL12741011 0.89 FFAR1 (0.47) TUBB1KDM4ELMNATACR2FFAR1
SCHEMBL12907042 0.88 TUBB1 (0.46) TUBB1KDM4ELMNAMAPTALDH1A1
SCHEMBL10302272 0.87 TACR2 (0.41) TUBB1KDM4ELMNATACR2FFAR1
SCHEMBL12740528 0.87 PPARD (0.54) TUBB1FFAR1PPARDPPARGPPARA
SCHEMBL12740139 0.86 FFAR1 (0.41) TUBB1KDM4ELMNAFFAR1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216489-B2 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-07-10 — — US disclosed
US-8216489-B2 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-07-10 — — US disclosed
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2011-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, L3MBTL3 TUBB1 548/4885KDM4E 2638/4885LMNA 239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback